Connect with us
JPMorgan Chase reduced its stake in Grifols from 3.09% to 2.99% as Brookfield seeks sovereign fund partners for a potential takeover bid. JPMorgan's 12.7 million shares...
Spanish pharmaceutical companies had mixed results: Almirall and Reig Jofre shares dropped by 4% and 2.5%, respectively, while Faes Farma and PharmaMar saw increases of around...
Grifols shares rose 2.6% following reports that Canadian firm Brookfield is in informal talks with sovereign funds for a takeover bid. Brookfield is seeking €9.5 billion...
In the first half of 2024, Novonesis achieved broad-based sales growth driven by Food&Health Biosolutions (6% growth to €876 million) and Planetary Health Biosolutions (8% growth...
Spain's medtech exports have surged, rising 41% since 2019 and 87% over the past decade. Key export categories include medical instruments (€354M), consumables (€297M), and orthopedic...
Valneva has partnered with LimmaTech Biologics to acquire exclusive rights to develop and market Shigella4V, a vaccine candidate against shigellosis. The agreement includes an upfront payment...
In phase 3 trials, Pfizer and BioNTech's vaccine showed strong immune responses against influenza A and COVID-19 but failed to meet key objectives for influenza B....
A U.S. judge ruled that Novartis lacked grounds to suspend the launch of MSN's generic version of Entresto but ordered a temporary production halt pending Novartis'...
Baxter plans to sell its renal business by early 2025 to reduce debt, continuing its strategy of divesting subsidiaries, including a $3.857 billion sale of Biopharma...
Eli Lilly is expanding its presence with the opening of a 346,000-square-foot facility in Boston, which will house 500 scientists and the first East Coast location...